A/Prof Mark Pinkham Newdegate Street, Greenslopes, Queensland 4120

Welcome to the webpage for A/Prof Mark Pinkham, a compassionate and detail-oriented specialist in cancer care. Located at Greenslopes, Newdegate Street in Australia, A/Prof Mark Pinkham is a renowned radiation oncologist and Adjunct Professor at Queensland University of Technology (QUT). He provides consultations at Icon Cancer Centre North Lakes and Greenslopes Private Hospital, and also serves as a Senior Staff Specialist at the Gamma Knife Centre of Queensland at the Princess Alexandra Hospital, where he holds the position of Director of Radiation Oncology Research.

With a strong educational background, A/Prof Mark Pinkham graduated from The University of Oxford, UK, in 2005 and completed a Masters in Physiological Sciences with a focus on the neurosciences in 2002. He then underwent specialist training in Brisbane in 2014, followed by an 18-month Clinical Oncology sub-specialty fellowship in neuro-oncology and intracranial stereotactic radiosurgery (SRS) at the prestigious Christie Hospital in the UK.

A/Prof Mark Pinkham has a keen research interest in melanoma and brain tumors, including brain metastases. He actively participates in the management of several clinical trials, aiming to improve treatments, imaging techniques, and survivorship issues for patients affected by these diseases. His contributions to the field are evident through his publication of over 40 manuscripts and acquisition of over AU$12 million in competitive research grant funding. A/Prof Mark Pinkham is a member of the Scientific Advisory Committee within the Co-operative Trials Group for Neuro-Oncology (COGNO) and serves as the inaugural Chair of the Brain Tumour (CNS) Working Party within TransTasman Radiation Oncology Group (TROG) across Australia and New Zealand.

Aside from his clinical and research commitments, A/Prof Mark Pinkham also enjoys sharing his knowledge and expertise through teaching. He serves as an examiner of medical trainees at the national level within the Royal Australian and New Zealand College of Radiologists (RANZCR) and acts as a supervisor to post-graduate research students at QUT and University of Queensland.

One of A/Prof Mark Pinkham's current endeavors is the Multi-Arm GlioblastoMa Australasia (MAGMA) Trial. This platform trial aims to assess various options in the standard of care for the management of glioblastoma. The trial poses important questions, including whether or not to administer a cycle of temozolomide prior to chemoradiotherapy and whether to give 6 or 12 cycles of temozolomide after chemoradiotherapy.

At A/Prof Mark Pinkham's institution, patients can expect high-quality cancer care with a strong emphasis on multidisciplinary collaboration and participation in clinical trials. With his expertise, dedication, and commitment to advancing cancer treatments, A/Prof Mark Pinkham is a trusted and respected figure in the field of radiation oncology in Australia.